Ten abstracts featuring Boehringer Ingelheim's investigational hepatitis C virus protease inhibitor, faldaprevir * and polymerase inhibitor, deleobuvir * will be presented at the 64 th Annual Meeting of the American Association for the Study of Liver Diseases 2013, 1-5 November, Washington.
http://www.etaiwannews.com/etn/news_content.php?id=2312944
http://www.etaiwannews.com/etn/news_content.php?id=2312944
No comments:
Post a Comment